Harvard Women's Health Watch Reviewed by Meghan Salamon, MS, RDN, LDN, CPT, Contributor After a year of using a GLP-1 medication to lose weight, Abby was ecstatic to have shed more than 100 pounds
GLP-1 medications are complex
Heres where that comes to life: Emotional cues: Increased self-criticism, weight preoccupation, withdrawal from social support Routine drift: Skipped workouts, inconsistent meals, loss of sleep hygiene Self-talk shifts: From Im managing it to Whats the point? Empathy Engine data show that nearly 1 in 5 adults with obesity experience high cognitive dissonancemeaning their beliefs and actions are out of sync, which can accelerate relapse once GLP-1 support is removed
Absorbance at 450 nm was measured using a plate reader (Synergy HTX)
Some patients may qualify if they have: -A BMI of 35 or higher -A BMI of 30+ with conditions such as chronic kidney disease, uncontrolled high blood pressure, or heart failure -A BMI of 27+ with prediabetes, a previous heart attack, previous stroke, or symptomatic peripheral artery disease You will not be eligible if you are already receiving a GLP-1 medication through your Medicare coverage for a preexisting condition such as: -Type 2 diabetes -Moderate-to-severe sleep apnea -Certain liver conditions, including MASH Call Montgomery Medical today at 724-569-8100 or go online to schedule a consultation and see if you may qualify for the Medicare GLP-1 Bridge Program
Evolving CMS Policy on Anti-Obesity Medications Historically, Medicare Part D excluded coverage for weight loss drugs under a statutory provision allowing Medicaid programs to do the same